Comera Life Sciences (CMRAW) Short Interest Ratio & Short Volume

Short interest is the volume of Comera Life Sciences shares that have been sold short but have not yet been closed out or covered. As of May 31st, investors have sold 200 shares of CMRAW short. Learn More on Comera Life Sciences' current short interest.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Comera Life Sciences: Calithera Biosciences, Inc. (0.43%), CytoMed Therapeutics Limited (1.24%), Eloxx Pharmaceuticals, Inc. (0.08%), Galapagos NV (2.95%), MEI Pharma, Inc. (0.04%), NexImmune, Inc. (0.31%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks.

Short selling CMRAW is an investing strategy that aims to generate trading profit from Comera Life Sciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Comera Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CMRAW, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CMRAW, twice per month. The most recent reporting period available is May, 31 2025.